发明名称 alpha2C ADRENORECEPTOR AGONIST
摘要 PROBLEM TO BE SOLVED: To provide a compound useful for treatment, prevention, or amelioration of diseases and disorders associated with anα2C adrenoreceptor agonist. SOLUTION: In many embodiments thereof, new phenylmorpholine and phenylthiomorpholine compounds useful as theα2C adrenorceptor receptor agonist, pharmaceutical compositions comprising the compounds, and methods for the treatment, prevention, inhibition, or amelioration of one or more diseases associated with theα2C adrenoreceptor agonist using the compounds or the pharmaceutical compositions are provided. In the many embodiments, a new class of heterocyclic compounds as active or functionally selectiveα2C adrenoreceptor agonists, or metabolites thereof, stereoisomers (e.g. enantiomers or diastereomers) salts, solvates, or polymorphs are provided. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009185016(A) 申请公布日期 2009.08.20
申请号 JP20080134858 申请日期 2008.05.22
申请人 SCHERING CORP;PHARMACOPEIA INC 发明人 MCCORMICK KEVIN D;BOYCE CHRISTOPHER W;SHIH NENG-YANG;ASLANIAN ROBERT G;MANGIARACINA PIETRO;DE LERA RUIZ MANUEL;YU YOUNONG;BIJU PURAKKATTLE J;HUANG CHIA-YU;LIANG BO;LIU RUIYAN;LIU RONG-QIANG;GUISE-ZAWACKI LISA
分类号 C07D403/06;A61K31/498;A61K31/4985;A61K31/538;A61K31/5383;A61K31/5415;A61K31/553;A61P9/04;A61P9/10;A61P25/06;A61P25/18;A61P27/06;A61P29/00;A61P43/00;C07D405/06;C07D409/06;C07D409/14;C07D417/06;C07D471/04;C07D498/04 主分类号 C07D403/06
代理机构 代理人
主权项
地址